MGMT and pituitary gland adenoma: Studies have suggested O6-methylguanine-DNA methyltransferase (MGMT) as the key factor responsible for chemoresistance of aggressive pituitary adenomas to the currently most promising chemotherapeutic drugs temozolomide (TMZ) and 2-methoxyestradiol (2ME) (Sharma et al., 2016).